Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-MSH modulates experimental inflammatory bowel disease

N Rajora1, G Boccoli, A Catania

  • 1Physiology Department, University of Texas Southwestern Medical Center at Dallas 75235-9040, USA.

Peptides
|January 1, 1997
PubMed
Summary

Alpha-melanocyte-stimulating hormone (alpha-MSH) peptide significantly reduced colitis symptoms in mice. This anti-inflammatory peptide offers a potential new treatment for inflammatory bowel disease (IBD).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.

The Journal of antimicrobial chemotherapy·2025
Same author

Exploring perceptions of factors aiding the development of critical thinking in adult dysphagia: A study among fourth-year speech-language pathology students.

The clinical teacher·2023
Same author

Three-trocar right colectomy - a video vignette.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

Bladder injury during rectal surgery - a video vignette.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2019
Same author

ZnT8 Arg325Trp polymorphism influences zinc transporter expression and cytokine production in PBMCs from patients with diabetes.

Diabetes research and clinical practice·2018
Same author

R106C TFG variant causes infantile neuroaxonal dystrophy "plus" syndrome.

Neurogenetics·2018

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Inflammatory bowel disease (IBD) mechanisms are unclear, but inflammation is central to its pathology.
  • Current IBD therapies primarily target inflammation, necessitating the search for novel, low-toxicity agents.
  • Alpha-melanocyte-stimulating hormone (alpha-MSH) is an anti-inflammatory and anticytokine peptide with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy of alpha-MSH in a murine model of colitis.
  • To determine if alpha-MSH can mitigate key indicators of experimental IBD.

Main Methods:

  • Administration of alpha-MSH to mice with experimentally induced colitis.
  • Assessment of clinical parameters including fecal blood, weight loss, and general condition.

Related Experiment Videos

  • Measurement of pro-inflammatory cytokine (TNF-alpha) and nitric oxide production in colonic tissues.

    • Main Results:

    • Alpha-MSH treatment markedly reduced fecal blood by over 80% and prevented weight loss.
    • General animal condition significantly improved with alpha-MSH administration.
    • Alpha-MSH significantly inhibited the production of TNF-alpha and nitric oxide in colonic tissues.

    Conclusions:

    • Alpha-MSH demonstrates significant therapeutic effects in a murine model of IBD.
    • The peptide may exert its beneficial effects by inhibiting local production of TNF-alpha and nitric oxide.
    • Alpha-MSH represents a promising candidate for the development of novel IBD treatments.